1. Home
  2. ULBI vs RPTX Comparison

ULBI vs RPTX Comparison

Compare ULBI & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ultralife Corporation

ULBI

Ultralife Corporation

HOLD

Current Price

$5.54

Market Cap

89.9M

Sector

Miscellaneous

ML Signal

HOLD

Logo Repare Therapeutics Inc.

RPTX

Repare Therapeutics Inc.

HOLD

Current Price

$2.15

Market Cap

92.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ULBI
RPTX
Founded
1990
2016
Country
United States
Canada
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.9M
92.4M
IPO Year
1992
2020

Fundamental Metrics

Financial Performance
Metric
ULBI
RPTX
Price
$5.54
$2.15
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$3.50
AVG Volume (30 Days)
43.1K
1.2M
Earning Date
11-18-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
$186,530,000.00
$11,870,000.00
Revenue This Year
$31.30
N/A
Revenue Next Year
$6.24
$9.55
P/E Ratio
$54.29
N/A
Revenue Growth
12.94
N/A
52 Week Low
$4.07
$0.89
52 Week High
$9.52
$4.07

Technical Indicators

Market Signals
Indicator
ULBI
RPTX
Relative Strength Index (RSI) 46.23 58.56
Support Level $5.40 $2.11
Resistance Level $5.72 $2.24
Average True Range (ATR) 0.23 0.06
MACD 0.05 -0.01
Stochastic Oscillator 63.08 43.75

Price Performance

Historical Comparison
ULBI
RPTX

About ULBI Ultralife Corporation

Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.

About RPTX Repare Therapeutics Inc.

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.

Share on Social Networks: